COVID-19 Impact on Global Childhood Absence Epilepsy Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 96 pages | ID: CC908CA731DFEN
QYResearch

Abstracts

This report focuses on the global Childhood Absence Epilepsy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Childhood Absence Epilepsy Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• GlaxoSmithKline
• Cavion Inc
• AbbVie
• Teva Pharmaceutical
• Insys Therapeutics

Market segment by Type, the product can be split into

• Ethosuximide
• Valproate
• Lamotrigine
• CX-8998
• Cannabidiol Oral Solution

Market segment by Application, split into

• Typical Absence Seizures
• Atypical Absence Seizures

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Childhood Absence Epilepsy Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Childhood Absence Epilepsy Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Childhood Absence Epilepsy Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Childhood Absence Epilepsy Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Childhood Absence Epilepsy Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Ethosuximide
  1.4.3 Valproate
  1.4.4 Lamotrigine
  1.4.5 CX-8998
  1.4.6 Cannabidiol Oral Solution
1.5 Market by Application
  1.5.1 Global Childhood Absence Epilepsy Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Typical Absence Seizures
  1.5.3 Atypical Absence Seizures
1.6 Coronavirus Disease 2019 (Covid-19): Childhood Absence Epilepsy Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Childhood Absence Epilepsy Treatment Industry
    1.6.1.1 Childhood Absence Epilepsy Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Childhood Absence Epilepsy Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Childhood Absence Epilepsy Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Childhood Absence Epilepsy Treatment Market Perspective (2015-2026)
2.2 Childhood Absence Epilepsy Treatment Growth Trends by Regions
  2.2.1 Childhood Absence Epilepsy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Childhood Absence Epilepsy Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Childhood Absence Epilepsy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Childhood Absence Epilepsy Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Childhood Absence Epilepsy Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Childhood Absence Epilepsy Treatment Players by Market Size
  3.1.1 Global Top Childhood Absence Epilepsy Treatment Players by Revenue (2015-2020)
  3.1.2 Global Childhood Absence Epilepsy Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Childhood Absence Epilepsy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Childhood Absence Epilepsy Treatment Market Concentration Ratio
  3.2.1 Global Childhood Absence Epilepsy Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Childhood Absence Epilepsy Treatment Revenue in 2019
3.3 Childhood Absence Epilepsy Treatment Key Players Head office and Area Served
3.4 Key Players Childhood Absence Epilepsy Treatment Product Solution and Service
3.5 Date of Enter into Childhood Absence Epilepsy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Childhood Absence Epilepsy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Childhood Absence Epilepsy Treatment Forecasted Market Size by Type (2021-2026)

5 CHILDHOOD ABSENCE EPILEPSY TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020)
5.2 Global Childhood Absence Epilepsy Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Childhood Absence Epilepsy Treatment Market Size (2015-2020)
6.2 Childhood Absence Epilepsy Treatment Key Players in North America (2019-2020)
6.3 North America Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020)
6.4 North America Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Childhood Absence Epilepsy Treatment Market Size (2015-2020)
7.2 Childhood Absence Epilepsy Treatment Key Players in Europe (2019-2020)
7.3 Europe Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020)
7.4 Europe Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Childhood Absence Epilepsy Treatment Market Size (2015-2020)
8.2 Childhood Absence Epilepsy Treatment Key Players in China (2019-2020)
8.3 China Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020)
8.4 China Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Childhood Absence Epilepsy Treatment Market Size (2015-2020)
9.2 Childhood Absence Epilepsy Treatment Key Players in Japan (2019-2020)
9.3 Japan Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020)
9.4 Japan Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Childhood Absence Epilepsy Treatment Market Size (2015-2020)
10.2 Childhood Absence Epilepsy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Childhood Absence Epilepsy Treatment Market Size (2015-2020)
11.2 Childhood Absence Epilepsy Treatment Key Players in India (2019-2020)
11.3 India Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020)
11.4 India Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Childhood Absence Epilepsy Treatment Market Size (2015-2020)
12.2 Childhood Absence Epilepsy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Childhood Absence Epilepsy Treatment Introduction
  13.1.4 Pfizer Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Details
  13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Childhood Absence Epilepsy Treatment Introduction
  13.2.4 GlaxoSmithKline Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020)
  13.2.5 GlaxoSmithKline Recent Development
13.3 Cavion Inc
  13.3.1 Cavion Inc Company Details
  13.3.2 Cavion Inc Business Overview and Its Total Revenue
  13.3.3 Cavion Inc Childhood Absence Epilepsy Treatment Introduction
  13.3.4 Cavion Inc Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020)
  13.3.5 Cavion Inc Recent Development
13.4 AbbVie
  13.4.1 AbbVie Company Details
  13.4.2 AbbVie Business Overview and Its Total Revenue
  13.4.3 AbbVie Childhood Absence Epilepsy Treatment Introduction
  13.4.4 AbbVie Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020)
  13.4.5 AbbVie Recent Development
13.5 Teva Pharmaceutical
  13.5.1 Teva Pharmaceutical Company Details
  13.5.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  13.5.3 Teva Pharmaceutical Childhood Absence Epilepsy Treatment Introduction
  13.5.4 Teva Pharmaceutical Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020)
  13.5.5 Teva Pharmaceutical Recent Development
13.6 Insys Therapeutics
  13.6.1 Insys Therapeutics Company Details
  13.6.2 Insys Therapeutics Business Overview and Its Total Revenue
  13.6.3 Insys Therapeutics Childhood Absence Epilepsy Treatment Introduction
  13.6.4 Insys Therapeutics Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020)
  13.6.5 Insys Therapeutics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Childhood Absence Epilepsy Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Childhood Absence Epilepsy Treatment Revenue
Table 3. Ranking of Global Top Childhood Absence Epilepsy Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Childhood Absence Epilepsy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ethosuximide
Table 6. Key Players of Valproate
Table 7. Key Players of Lamotrigine
Table 8. Key Players of CX-8998
Table 9. Key Players of Cannabidiol Oral Solution
Table 10. COVID-19 Impact Global Market: (Four Childhood Absence Epilepsy Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Childhood Absence Epilepsy Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Childhood Absence Epilepsy Treatment Players to Combat Covid-19 Impact
Table 15. Global Childhood Absence Epilepsy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Childhood Absence Epilepsy Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Childhood Absence Epilepsy Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Childhood Absence Epilepsy Treatment Market Share by Regions (2015-2020)
Table 19. Global Childhood Absence Epilepsy Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Childhood Absence Epilepsy Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Childhood Absence Epilepsy Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Childhood Absence Epilepsy Treatment Players
Table 26. Global Childhood Absence Epilepsy Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Childhood Absence Epilepsy Treatment Market Share by Players (2015-2020)
Table 28. Global Top Childhood Absence Epilepsy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Childhood Absence Epilepsy Treatment as of 2019)
Table 29. Global Childhood Absence Epilepsy Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Childhood Absence Epilepsy Treatment Product Solution and Service
Table 32. Date of Enter into Childhood Absence Epilepsy Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Childhood Absence Epilepsy Treatment Market Size Share by Type (2015-2020)
Table 36. Global Childhood Absence Epilepsy Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Childhood Absence Epilepsy Treatment Market Size Share by Application (2015-2020)
Table 38. Global Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Childhood Absence Epilepsy Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Childhood Absence Epilepsy Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Childhood Absence Epilepsy Treatment Market Share (2019-2020)
Table 42. North America Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Childhood Absence Epilepsy Treatment Market Share by Type (2015-2020)
Table 44. North America Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Childhood Absence Epilepsy Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Childhood Absence Epilepsy Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Childhood Absence Epilepsy Treatment Market Share (2019-2020)
Table 48. Europe Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Childhood Absence Epilepsy Treatment Market Share by Type (2015-2020)
Table 50. Europe Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Childhood Absence Epilepsy Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Childhood Absence Epilepsy Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Childhood Absence Epilepsy Treatment Market Share (2019-2020)
Table 54. China Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Childhood Absence Epilepsy Treatment Market Share by Type (2015-2020)
Table 56. China Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Childhood Absence Epilepsy Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Childhood Absence Epilepsy Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Childhood Absence Epilepsy Treatment Market Share (2019-2020)
Table 60. Japan Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Childhood Absence Epilepsy Treatment Market Share by Type (2015-2020)
Table 62. Japan Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Childhood Absence Epilepsy Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Childhood Absence Epilepsy Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Childhood Absence Epilepsy Treatment Market Share (2019-2020)
Table 66. Southeast Asia Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Childhood Absence Epilepsy Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Childhood Absence Epilepsy Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Childhood Absence Epilepsy Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Childhood Absence Epilepsy Treatment Market Share (2019-2020)
Table 72. India Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Childhood Absence Epilepsy Treatment Market Share by Type (2015-2020)
Table 74. India Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Childhood Absence Epilepsy Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Childhood Absence Epilepsy Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Childhood Absence Epilepsy Treatment Market Share (2019-2020)
Table 78. Central & South America Childhood Absence Epilepsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Childhood Absence Epilepsy Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Childhood Absence Epilepsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Childhood Absence Epilepsy Treatment Market Share by Application (2015-2020)
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Product
Table 85. Pfizer Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020) (Million US$)
Table 86. Pfizer Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Product
Table 90. GlaxoSmithKline Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020) (Million US$)
Table 91. GlaxoSmithKline Recent Development
Table 92. Cavion Inc Company Details
Table 93. Cavion Inc Business Overview
Table 94. Cavion Inc Product
Table 95. Cavion Inc Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020) (Million US$)
Table 96. Cavion Inc Recent Development
Table 97. AbbVie Company Details
Table 98. AbbVie Business Overview
Table 99. AbbVie Product
Table 100. AbbVie Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020) (Million US$)
Table 101. AbbVie Recent Development
Table 102. Teva Pharmaceutical Company Details
Table 103. Teva Pharmaceutical Business Overview
Table 104. Teva Pharmaceutical Product
Table 105. Teva Pharmaceutical Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020) (Million US$)
Table 106. Teva Pharmaceutical Recent Development
Table 107. Insys Therapeutics Company Details
Table 108. Insys Therapeutics Business Overview
Table 109. Insys Therapeutics Product
Table 110. Insys Therapeutics Revenue in Childhood Absence Epilepsy Treatment Business (2015-2020) (Million US$)
Table 111. Insys Therapeutics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Childhood Absence Epilepsy Treatment Market Share by Type: 2020 VS 2026
Figure 2. Ethosuximide Features
Figure 3. Valproate Features
Figure 4. Lamotrigine Features
Figure 5. CX-8998 Features
Figure 6. Cannabidiol Oral Solution Features
Figure 7. Global Childhood Absence Epilepsy Treatment Market Share by Application: 2020 VS 2026
Figure 8. Typical Absence Seizures Case Studies
Figure 9. Atypical Absence Seizures Case Studies
Figure 10. Childhood Absence Epilepsy Treatment Report Years Considered
Figure 11. Global Childhood Absence Epilepsy Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Childhood Absence Epilepsy Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Childhood Absence Epilepsy Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Childhood Absence Epilepsy Treatment Market Share by Players in 2019
Figure 16. Global Top Childhood Absence Epilepsy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Childhood Absence Epilepsy Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Childhood Absence Epilepsy Treatment Revenue in 2019
Figure 18. North America Childhood Absence Epilepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Childhood Absence Epilepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Childhood Absence Epilepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Childhood Absence Epilepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Childhood Absence Epilepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Childhood Absence Epilepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Childhood Absence Epilepsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Childhood Absence Epilepsy Treatment Business (2015-2020)
Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Revenue Growth Rate in Childhood Absence Epilepsy Treatment Business (2015-2020)
Figure 29. Cavion Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Cavion Inc Revenue Growth Rate in Childhood Absence Epilepsy Treatment Business (2015-2020)
Figure 31. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AbbVie Revenue Growth Rate in Childhood Absence Epilepsy Treatment Business (2015-2020)
Figure 33. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Teva Pharmaceutical Revenue Growth Rate in Childhood Absence Epilepsy Treatment Business (2015-2020)
Figure 35. Insys Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Insys Therapeutics Revenue Growth Rate in Childhood Absence Epilepsy Treatment Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed